We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PL icon
13751
CALL
Planet Labs
PL
$8.8B
$1.56K ﹤0.01%
600
-44,900
-99% -$143K
IDN icon
13752
PUT
Intellicheck
IDN
$56.9M
$1.55K ﹤0.01%
700
-1,100
-61% -$2.77K
DMAC icon
13753
PUT
DiaMedica Therapeutics
DMAC
$360M
$1.55K ﹤0.01%
600
+400
+200% +$1.28K
IBEX icon
13754
CALL
IBEX
IBEX
$480M
$1.54K ﹤0.01%
100
-1,900
-95% -$35.5K
KVHI icon
13755
CALL
KVH Industries
KVHI
$145M
$1.53K ﹤0.01%
300
NPABW
13756
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$1.52K ﹤0.01%
25,445
+11,927
+88% +$900
OKUR
13757
PUT
OnKure Therapeutics
OKUR
$162M
$1.52K ﹤0.01%
+20
New +$1.36K
FNVTW
13758
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
$1.52K ﹤0.01%
32,542
+7,286
+29% +$299
OXSQ icon
13759
PUT
Oxford Square Capital
OXSQ
$157M
$1.5K ﹤0.01%
500
+400
+400% +$1.21K
GWH icon
13760
PUT
ESS Tech
GWH
$20.4M
$1.5K ﹤0.01%
53
-167
-76% -$4.06K
NFNT.WS
13761
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$1.5K ﹤0.01%
37,563
+27,194
+262% +$3.21K
SCTL
13762
CALL
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.5K ﹤0.01%
3,200
+1,400
+78% +$999
TIMB icon
13763
PUT
TIM SA
TIMB
$8.29B
$1.49K ﹤0.01%
100
-3,700
-97% -$55.3K
EVE.WS
13764
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$1.49K ﹤0.01%
+37,093
New +$2.94K
BDSX icon
13765
PUT
Biodesix
BDSX
$253M
$1.49K ﹤0.01%
+45
New +$1.25K
SHUAW
13766
DELISTED
SHUAA Partners Acquisition Corp I Warrant
SHUAW
$1.49K ﹤0.01%
23,462
+2,638
+13% +$197
HOOK
13767
PUT
DELISTED
HOOKIPA Pharma
HOOK
$1.48K ﹤0.01%
240
-210
-47% -$1.54K
NECB icon
13768
PUT
Northeast Community Bancorp
NECB
$372M
$1.48K ﹤0.01%
+100
New +$1.57K
INTZ
13769
CALL
DELISTED
INTRUSION INC NEW
INTZ
$1.47K ﹤0.01%
4,200
+700
+20% +$244
SIFY
13770
PUT
Sify Technologies
SIFY
$1.13B
$1.46K ﹤0.01%
133
-250
-65% -$3.21K
HYPD
13771
Hyperion DeFi Inc
HYPD
$41.2M
$1.46K ﹤0.01%
11
-237
-96% -$38.1K
NGS icon
13772
PUT
Natural Gas Services Group
NGS
$490M
$1.46K ﹤0.01%
100
-8,600
-99% -$93.7K
VIRX
13773
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.46K ﹤0.01%
1,400
-1,400
-50% -$1.9K
EZRAW
13774
DELISTED
Reliance Global Series A Warrants
EZRAW
$1.46K ﹤0.01%
14,737
+4,717
+47% +$442
KLR
13775
CALL
DELISTED
Kaleyra, Inc.
KLR
$1.45K ﹤0.01%
+200
New +$1.37K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.